OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Neil Vasdev

2 Projects | 1 Researchers | $506,805 Invested

2015

Massachusetts General Hospital (P)

Neil Vasdev, PhD

Translation of an optimized PET radiopharmaceutical for imaging tau pathology in Alzheimer's patients

  • Funding Amount: $331,805
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Tau
  • Status: Closed

2012

Massachusetts General Hospital (P)

Neil Vasdev, PhD

Radiopharmaceutical Development for Imaging Metabotropic Glutamate Subtype 5 Receptors (mGluR5) in AD patients with PET

  • Funding Amount: $175,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed